Avacta Therapeutics has reported outcomes from the Phase Ia trial of AVA6000, a drug candidate for solid tumours.

Amgen’s LUMAKRAS and Vectibix combination has received approval from the US FDA for treating KRAS G12C-mutated mCRC.

The EC has approved GSK's Jemperli (dostarlimab) combined with chemotherapy for primary advanced or recurrent endometrial cancer in adults.

Topline results from the Chinese portion of the trial for the antibody-drug conjugate (ADC) TIVDAK support the company’s regulatory plans.

Unlike the roles that some play on-screen, stars don't always get a happy ending. Too many famous figures die under ...

An Orange County Superior Court judge Friday praised a proposed $233 million settlement with Disney in a class action suit stemming from a dispute over Anaheim’s minimum wage law and could be on track ...

Sentencing is set Wednesday for two men charged with lesser crimes as two other defendants await trial on a murder charge stemming from last year’s killing of former “General Hospital” actor Johnny ...

The 47th US president announced on his social media platform Truth Social at 12.38 am (5.38 am GMT) that four officials “not ...

The president ordered the withdrawal of the country from the Paris climate agreement and took action on immigration policy ...

JP Morgan analyst Matthew Boss reiterated an Overweight rating on the shares of Viking Holdings Ltd (NYSE:VIK) and raised the ...